glp 1 epilepsy GLP-1 receptor agonists in people with epilepsy: A scoping review of clinical data, safety, and therapeutic implications Seizure Recurrence after GLP-1 Receptor

A clinical trial exploring CoreBiome for weight loss was terminated due to lack of funding, so its potential benefits in humans remain unknown

Moreover, the intervention significantly reduced Falls Efficacy Scale scores and exhibited a trend toward decreased fall incidence, thereby improving postural balance, lower-limb neuromuscular function, and motor confidence, ultimately reducing fall risk in this population (Thiel et al., 2025)

However, further research is needed on this topic [170,171]

Why hydroxocobalamin over cyanocobalamin

The Case for Morning Intake Taking glutathione first thing in the morning is a popular strategy for those seeking daytime protection

A first step in understanding SARS pathogenesis